XML 65 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Based Compensation Plans
The Company has three active stock-based compensation plans at June 30, 2024 as shown in the table below:
Date ApprovedName of PlanType of PlanAuthorized
Shares
June 20142014 Stock Option Incentive PlanStock options750,000 
June 20152015 Equity Incentive PlanStock & stock options1,250,000 
April 20182018 Equity Incentive PlanStock & stock options10,000,000 
12,000,000 
Schedule of Common Stock for Future Issuance
As of June 30, 2024, the Company had reserved shares of Common Stock for future issuance for the following:
Common StockReserved Shares
Conversions of Preferred Stock and cumulative Preferred Stock dividends95,558 
Issuance of shares to former executive upon the occurrence of a Cantaloupe transaction (1)
140,000 
Total shares reserved for future issuance235,558 
(1)Represents 140,000 shares issuable to our former executive upon the occurrence of a "USA Transaction" as such term is defined in the stock agreement.
As of June 30, 2024, the Company had the following shares available for issuance under the respective incentive plans:
Incentive Plan
Available Options
Issuance under 2014 Stock Option Incentive Plan15,687 
Issuance under 2015 Equity Incentive Plan369,157 
Issuance under 2018 Equity Incentive Plan4,170,267 
Total options available for future issuance
4,555,111 
Schedule of Stock Option Granted Weighted Average Assumptions
The fair value of options granted during the years ended June 30, 2024, 2023, and 2022 was determined using the following assumptions:
For the year ended June 30,
202420232022
Expected volatility
52.6 - 69.7%
74.6 - 77.6%
73.2 - 74.6%
Expected life (years)
4.2 - 4.5
4.4 - 4.6
4.5 - 4.6
Expected dividends0.0%0.0%0.0%
Risk-free interest rate
4.0 - 4.4%
2.7 - 4.1%
1.0 - 2.9%
Schedule of Information Related to Outstanding Options
The following tables provide information about outstanding options for the years ended June 30, 2024, 2023, and 2022:
For the year ended June 30, 2024
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of year
3,873,632 $6.35 5.1$7,595 
Granted175,000 $6.92 
Exercised(18,334)$6.06 $— 
Forfeited(29,799)$6.90 
Expired(28,665)$4.40 
Outstanding options, end of year
3,971,834 $6.63 4.3$3,582 
Exercisable options, end of year
2,602,259 $7.28 3.8$1,085 

For the year ended June 30, 2023
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of year
3,529,833 $7.41 4.5$194 
Granted1,720,000 $4.61 
Exercised— $— $— 
Forfeited(1,376,201)$6.86 
Expired— $— 
Outstanding options, end of year
3,873,632 $6.35 5.1$7,595 
Exercisable options, end of year
1,341,466 $7.26 3.9$1,536 

For the year ended June 30, 2022
Number of OptionsWeighted Average
Exercise Price		Weighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
(in thousands)
Outstanding options, beginning of year
2,952,092 $6.97 5.6$14,419 
Granted904,500 $8.86 
Exercised(121,248)$6.30 $(53)
Forfeited(205,511)$8.09 
Expired— $— 
Outstanding options, end of year
3,529,833 $7.41 4.5$194 
Exercisable options, end of year
1,538,302 $6.79 4.5$183 
Schedule of Nonvested Share Activity
A summary of the status of the Company’s nonvested common shares and RSUs as of June 30, 2024, 2023, and 2022, and changes during the years then ended is presented below:
SharesWeighted-Average
Grant-Date
Fair Value
Nonvested at June 30, 2021137,846 $9.57 
Granted507,729 $7.33 
Vested(101,515)$10.34 
Forfeited(95,152)$8.89 
Nonvested at June 30, 2022448,908 $7.00 
Granted346,346 $5.41 
Vested(274,011)$5.96 
Forfeited(97,342)$8.27 
Nonvested at June 30, 2023423,901 $6.08 
Granted439,363 $6.72 
Vested(311,093)$6.38 
Forfeited(4,207)$7.58 
Nonvested at June 30, 2024547,964 $6.41 
Schedule of Stock-based Compensation Expense
A summary of the Company's stock-based compensation expense recognized during the years ended June 30, 2024, 2023, and 2022 is as follows:
($ in thousands)For the year ended June 30,
Award type202420232022
Stock options$2,992 $2,967 $4,424 
Stock grants2,117 1,770 1,824 
Total stock-based compensation expense$5,109 $4,737 $6,248 
A summary of the Company's unrecognized stock-based compensation expense as of June 30, 2024 is as follows:
As of June 30, 2024
Award typeUnrecognized Expense
(in thousands)		Weighted Average Recognition Period
(in years)
Stock options$1,566 1.3
Stock grants$2,225 1.5